Mark Sheptoff Financial Planning, LLC Vertex Pharmaceuticals Inc Transaction History
Mark Sheptoff Financial Planning, LLC
- $179 Million
- Q1 2024
A detailed history of Mark Sheptoff Financial Planning, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mark Sheptoff Financial Planning, LLC holds 11,346 shares of VRTX stock, worth $5.32 Million. This represents 2.65% of its overall portfolio holdings.
Number of Shares
11,346
Previous 11,296
0.44%
Holding current value
$5.32 Million
Previous $4.6 Million
3.18%
% of portfolio
2.65%
Previous 2.78%
Shares
24 transactions
Others Institutions Holding VRTX
# of Institutions
1,623Shares Held
222MCall Options Held
1.35MPut Options Held
1.49M-
Capital World Investors Los Angeles, CA25.6MShares$12 Billion1.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA22.7MShares$10.6 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY22MShares$10.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA12MShares$5.63 Billion0.23% of portfolio
-
Alliancebernstein L.P. New York, NY7.1MShares$3.33 Billion1.08% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $120B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...